Partial agonists activate PPARγ using a helix 12 independent mechanism

被引:313
作者
Bruning, John B.
Chalmers, Michael J.
Prasad, Swati
Busby, Scott A.
Karnenecka, Theodore M.
He, Yuanjun
Nettles, Kendall W.
Griffin, Patrick R.
机构
[1] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA
[2] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA
[3] Scripps Res Inst, Dept Med Chem, Jupiter, FL 33458 USA
关键词
D O I
10.1016/j.str.2007.07.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Binding to helix 12 of the ligand-binding domain of PPAR gamma is required for full agonist activity. Previously, the degree of stabilization of the activation function 2 (AF-2) surface was thought to correlate with the degree of agonism and transactivation. To examine this mechanism, we probed structural dynamics of PPAR gamma with agonists that induced graded transcriptional responses. Here we present crystal structures and amide H/D exchange (HDX) kinetics for six of these complexes. Amide HDX revealed each ligand induced unique changes to the dynamics of the ligand-binding domain (LBD). Full agonists stabilized helix 12, whereas intermediate and partial agonists did not at all, and rather differentially stabilized other regions of the binding pocket. The gradient of PPAR gamma transactivation cannot be accounted for solely through changes to the dynamics of AF-2. Thus, our understanding of allosteric signaling must be extended beyond the idea of a dynamic helix 12 acting as a molecular switch.
引用
收藏
页码:1258 / 1271
页数:14
相关论文
共 48 条
  • [1] Benzoyl 2-methyl indoles as selective PPARγ modulators
    Acton, JJ
    Black, RM
    Jones, AB
    Moller, DE
    Colwell, L
    Doebber, TW
    MacNaul, KL
    Berger, J
    Wood, HB
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (02) : 357 - 362
  • [2] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [3] IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor γ1
    Bendixen, AC
    Shevde, NK
    Dienger, KM
    Willson, TM
    Funk, CD
    Pike, JW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) : 2443 - 2448
  • [4] Berger Joel, 2002, Diabetes Technol Ther, V4, P163, DOI 10.1089/15209150260007381
  • [5] Distinct properties and advantages of a novel peroxisome proliferator-activated protein γ selective modulator
    Berger, JP
    Petro, AE
    Macnaul, KL
    Kelly, LJ
    Zhang, BB
    Richards, K
    Elbrecht, A
    Johnson, BA
    Zhou, GC
    Doebber, TW
    Biswas, C
    Parikh, M
    Sharma, N
    Tanen, MR
    Thompson, GM
    Ventre, J
    Adams, AD
    Mosley, R
    Surwit, RS
    Moller, DE
    [J]. MOLECULAR ENDOCRINOLOGY, 2003, 17 (04) : 662 - 676
  • [6] PPARs: therapeutic targets for metabolic disease
    Berger, JP
    Akiyama, TE
    Meinke, PT
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (05) : 244 - 251
  • [7] A novel partial agonist of peroxisome proliferator-activated receptor-γ (PPARγ) recruits PPARγ-coactivator-1α, prevents triglyceride accumulation, and potentiates insulin signaling in vitro
    Burgermeister, E
    Schnoebelen, A
    Flament, A
    Benz, J
    Stihle, M
    Gsell, B
    Rufer, A
    Ruf, A
    Kuhn, B
    Märki, HP
    Mizrahi, J
    Sebokova, E
    Niesor, E
    Meyer, M
    [J]. MOLECULAR ENDOCRINOLOGY, 2006, 20 (04) : 809 - 830
  • [8] Probing protein ligand interactions by automated hydrogen/deuterium exchange mass spectrometry
    Chalmers, MJ
    Busby, SA
    Pascal, BD
    He, YJ
    Hendrickson, CL
    Marshall, AG
    Griffin, PR
    [J]. ANALYTICAL CHEMISTRY, 2006, 78 (04) : 1005 - 1014
  • [9] Nuclear receptors and lipid physiology: Opening the X-files
    Chawla, A
    Repa, JJ
    Evans, RM
    Mangelsdorf, DJ
    [J]. SCIENCE, 2001, 294 (5548) : 1866 - 1870
  • [10] Structure of the PPARα and -γ ligand binding domain in complex with AZ 242;: Ligand selectivity and agonist activation in the PPAR family
    Cronet, P
    Petersen, JFW
    Folmer, R
    Blomberg, N
    Sjöblom, K
    Karlsson, U
    Lindstedt, EL
    Bamberg, K
    [J]. STRUCTURE, 2001, 9 (08) : 699 - 706